|
Volumn 29, Issue 3, 2002, Pages 191-195
|
Second EBMT workshop on reduced intensity allogeneic hemopoietic stem cell transplants (RI-HSCT)
a |
Author keywords
Graft versus host disease; Hemopoietic stem cell transplants; Reduced intensity conditioning regimen
|
Indexed keywords
ALEMTUZUMAB;
ALKYLATING AGENT;
BUSULFAN;
CYCLOPHOSPHAMIDE;
CYCLOSPORIN A;
FLUDARABINE;
MELPHALAN;
T LYMPHOCYTE ANTIBODY;
THIOTEPA;
THYMOCYTE ANTIBODY;
ACUTE LEUKEMIA;
ADULT;
AGED;
ALLOTRANSPLANTATION;
ARTICLE;
CHRONIC LEUKEMIA;
CLINICAL PROTOCOL;
CONTROLLED STUDY;
DRUG ACTIVITY;
GERMANY;
GRAFT VERSUS HOST REACTION;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMAN;
MAJOR CLINICAL STUDY;
MORBIDITY;
MORTALITY;
PRIORITY JOURNAL;
PROSPECTIVE STUDY;
RETROSPECTIVE STUDY;
RISK ASSESSMENT;
SOLID TUMOR;
STEM CELL MOBILIZATION;
WHOLE BODY RADIATION;
WORKSHOP;
EDUCATION;
GRAFT VS HOST DISEASE;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMANS;
RETROSPECTIVE STUDIES;
TRANSPLANTATION CONDITIONING;
TRANSPLANTATION, HOMOLOGOUS;
|
EID: 0036184602
PISSN: 02683369
EISSN: None
Source Type: Journal
DOI: 10.1038/sj.bmt.1703355 Document Type: Article |
Times cited : (53)
|
References (14)
|